Pharmacotherapy for Substance Use Disorders.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27235620.
- Also identified by DOI 10.1016/j.mcna.2016.03.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This article reviews the current pharmacotherapy options available for the treatment of patients with substance use disorders. In the United States there are medications available to treat tobacco use disorders (nicotine replacement, bupropion, and varenicline), alcohol use disorders (naltrexone and acamprosate), and opioid use disorders (methadone and buprenorphine). These medications are likely underused and physicians should more readily prescribe for eligible patients.
Medical subject headings
- Substance-Related Disorders